Dermacyte

N/A

Report date: 2024/12/20 13:57:29

Base Information

Drug NameDermacyte
Drug Alias NameDermacyte LiquidDermacyte Amniotic Wound Care Liquidhuman amniotic fluidMTX-001
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionTissue replacements
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)UlcerSurgical Wound Dehiscence +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerakris Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityMerakris Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)UlcerSurgical Wound Dehiscence +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A